|
LYST expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.341600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.182200E-01 |
| Normal-vs-Stage2 |
1.127440E-01 |
| Normal-vs-Stage3 |
3.161400E-01 |
| Normal-vs-Stage4 |
4.721400E-01 |
| Stage1-vs-Stage2 |
1.843590E-01 |
| Stage1-vs-Stage3 |
5.714800E-01 |
| Stage1-vs-Stage4 |
6.000400E-01 |
| Stage2-vs-Stage3 |
3.557200E-01 |
| Stage2-vs-Stage4 |
6.829600E-01 |
| Stage3-vs-Stage4 |
7.570400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.206800E-01 |
| Normal-vs-AfricanAmerican |
1.654010E-01 |
| Normal-vs-Asian |
8.753400E-01 |
| Caucasian-vs-AfricanAmerican |
3.388800E-01 |
| Caucasian-vs-Asian |
9.961400E-01 |
| AfricanAmerican-vs-Asian |
7.285000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.981800E-01 |
| Normal-vs-Female |
6.281700E-03 |
| Male-vs-Female |
5.215600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.324000E-01 |
| Normal-vs-Extreme_Weight |
4.291200E-01 |
| Normal-vs-Obese |
5.361500E-02 |
| Normal-vs-Extreme_Obese |
2.836200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.971600E-01 |
| Normal_Weight-vs-Obese |
8.414300E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.945200E-01 |
| Extreme_Weight-vs-Obese |
2.399800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.372800E-01 |
| Obese-vs-Extreme_Obese |
3.123600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.706400E-02 |
| Normal-vs-Age(41-60Yrs) |
9.621600E-02 |
| Normal-vs-Age(61-80Yrs) |
4.601400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.576400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.120370E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.707690E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.478430E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.785800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.95930000000444E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.762900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.571400E-01 |
| Normal-VS-Type2 PRCC |
5.112200E-01 |
| Normal-VS-KIRP CIMP |
2.077800E-02 |
| Normal-VS-Unclassified PRCC |
1.672570E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.583400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.624000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.452300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.234300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.888800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.047600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.944800E-01 |
| Normal-vs-N1 |
6.020000E-02 |
| Normal-vs-N2 |
1.734210E-01 |
| N0-vs-N1 |
9.314400E-02 |
| N0-vs-N2 |
5.048400E-01 |
| N1-vs-N2 |
1.750360E-01 |
|
|
